| dc.contributor.author | Van Ganse, Eric | |
| dc.contributor.author | Texier, Nathalie | |
| dc.contributor.author | Dima, Alexandra L. | |
| dc.contributor.author | Laforest, Laurent | |
| dc.contributor.author | Ferrer, Montserrat | |
| dc.contributor.author | Hernandez, Gimena | |
| dc.contributor.author | Schuck, Stéphane | |
| dc.contributor.author | Herbage, Sandrine | |
| dc.contributor.author | Vial, Delphine | |
| dc.contributor.author | De Bruin, Marijn | |
| dc.date.accessioned | 2015-08-13T15:20:02Z | |
| dc.date.available | 2015-08-13T15:20:02Z | |
| dc.date.issued | 2015-06-18 | |
| dc.identifier.citation | Van Ganse , E , Texier , N , Dima , A L , Laforest , L , Ferrer , M , Hernandez , G , Schuck , S , Herbage , S , Vial , D & De Bruin , M 2015 , ' Assessment of the safety of long-acting β <inf >2 </inf > -agonists in routine asthma care : The ASTRO-LAB protocol ' , npj Primary Care Respiratory Medicine , vol. 25 , 15040 . https://doi.org/10.1038/npjpcrm.2015.40 | en |
| dc.identifier.other | PURE: 54985532 | |
| dc.identifier.other | PURE UUID: 1b578bb7-ba27-4121-b981-ed766e6a2a39 | |
| dc.identifier.other | Scopus: 84935005937 | |
| dc.identifier.uri | http://hdl.handle.net/2164/4818 | |
| dc.description | ASTRO-LAB is funded by the European Commission through the Seventh Framework Program (FP7-Grant Agreement n° 282 593) and gathers seven partners in a Consortium: Université Claude Bernard Lyon 1, University of Nottingham, Kappa Santé SAS, Cegedim Strategic Data Medical Research Limited, University of Amsterdam, Consortio Mar Parc de Salut de Barcelona and Lyon Ingénierie Projets. | en |
| dc.format.extent | 5 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | npj Primary Care Respiratory Medicine | en |
| dc.rights | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | RA Public aspects of medicine | en |
| dc.subject | Public Health, Environmental and Occupational Health | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.subject.lcc | RA | en |
| dc.title | Assessment of the safety of long-acting β<inf>2</inf> -agonists in routine asthma care : The ASTRO-LAB protocol | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.University of Aberdeen | en |
| dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Health Psychology Group | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1038/npjpcrm.2015.40 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=84935005937&partnerID=8YFLogxK | en |
| dc.identifier.vol | 25 | en |
